Julie Vose
University of Nebraska Medical Center

Last Updated On 4/8/2022 4:56:05 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
Company: Acerta Pharma/AstraZeneca
Recipient: You
Company: Roche/Genentech
Recipient: You
Company: Morphosys
Recipient: You
Company: Conjupro Biotherapeutics
Recipient: You
Company: Octernal
Recipient: You
Company: Johnson and Johnson
Recipient: You
Company: MEI Pharma
Recipient: You
Company: Lilly
Recipient: You

Consulting or Advisory Role
No Relationships to Disclose

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Loxo
Recipient: You
Company: Epizyme
Recipient: You
Company: Celgene
Recipient: Your Institution
Company: Incyte
Recipient: Your Institution
Company: Acerta Pharma
Recipient: Your Institution
Company: Kite Pharma
Recipient: Your Institution
Company: Seattle Genetics
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: AstraZeneca
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
not answered

(OPTIONAL) Open Payments Link
not answered